Historically, stored product insect pest management has been based around the use of methyl bromide and phosphine as fumigants. However, methyl bromide has been phased out for structural fumigations, ...and there is increasing worldwide insecticide resistance to phosphine. One potential alternative, environmentally friendly option is the use of methyl benzoate (MBe), which is considered a food safe compound. In this study, we evaluated the direct and sublethal effects of MBe exposure on the survivorship and mobility of four stored product species with diverse life histories, including Rhyzopertha dominica, Tribolium castaneum, Sitophilus zeamais, and Trogoderma variabile. Sets of insects were exposed to a control, low, or high MBe concentrations in flasks with or without food for 24 or 72 h in the laboratory. Furthermore, we assessed phosphine exposure under similar conditions. Overall, R. dominica was the most susceptible to MBe exposure, followed by T. castaneum. By contrast, S. zeamais and T. variabile were relatively unaffected by MBe exposure. Exposure to MBe induced multiple-fold decreases in the total distance moved and velocity of adults still considered alive or affected after assays. By comparison, phosphine effectively killed all individuals of all species. Our data suggest that while MBe was effective for R. dominica, it was not competitive in comparison to phosphine for controlling susceptible strains of these species at the specified experimental conditions.
Summary Background Bivalirudin, with selective use of glycoprotein (GP) IIb/IIIa inhibitor agents, is an accepted standard of care in primary percutaneous coronary intervention (PPCI). We aimed to ...compare antithrombotic therapy with bivalirudin or unfractionated heparin during this procedure. Methods In our open-label, randomised controlled trial, we enrolled consecutive adults scheduled for angiography in the context of a PPCI presentation at Liverpool Heart and Chest Hospital (Liverpool, UK) with a strategy of delayed consent. Before angiography, we randomly allocated patients (1:1; stratified by age <75 years vs ≥75 years and presence of cardiogenic shock yes vs no) to heparin (70 U/kg) or bivalirudin (bolus 0·75 mg/kg; infusion 1·75 mg/kg per h). Patients were followed up for 28 days. The primary efficacy outcome was a composite of all-cause mortality, cerebrovascular accident, reinfarction, or unplanned target lesion revascularisation. The primary safety outcome was incidence of major bleeding (type 3–5 as per Bleeding Academic Research Consortium definitions). This study is registered with ClinicalTrials.gov , number NCT01519518. Findings Between Feb 7, 2012, and Nov 20, 2013, 1829 of 1917 patients undergoing emergency angiography at our centre (representing 97% of trial-naive presentations) were randomly allocated treatment, with 1812 included in the final analyses. 751 (83%) of 905 patients in the bivalirudin group and 740 (82%) of 907 patients in the heparin group had a percutaneous coronary intervention. The rate of GP IIb/IIIa inhibitor use was much the same between groups (122 patients 13% in the bivalirudin group and 140 patients 15% in the heparin group). The primary efficacy outcome occurred in 79 (8·7%) of 905 patients in the bivalirudin group and 52 (5·7%) of 907 patients in the heparin group (absolute risk difference 3·0%; relative risk RR 1·52, 95% CI 1·09–2·13, p=0·01). The primary safety outcome occurred in 32 (3·5%) of 905 patients in the bivalirudin group and 28 (3·1%) of 907 patients in the heparin group (0·4%; 1·15, 0·70–1·89, p=0·59). Interpretation Compared with bivalirudin, heparin reduces the incidence of major adverse ischaemic events in the setting of PPCI, with no increase in bleeding complications. Systematic use of heparin rather than bivalirudin would reduce drug costs substantially. Funding Liverpool Heart and Chest Hospital, UK National Institute of Health Research, The Medicines Company, AstraZeneca, The Bentley Drivers Club (UK).
Stored products represent an enormous economic output, but insects regularly immigrate into stored products from the surrounding landscape throughout the postharvest supply chain. Long-lasting ...insecticide-incorporatednetting (LLIN), which usually contains an incorporated pyrethroid, has been used as part of a strategy to reduce the spread of malaria in tropical regions since the 1990s and has only recently been considered for its application in pre- and postharvest agricultural contexts. The goal of this study was to determine how short-term exposure to LLINs in the laboratory impacts the locomotory behavior and mortality for adult Tribolium castaneum (Herbst), (Coleoptera: Tenebrionidae) red flour beetle, and Rhyzopertha dominica (Fauvel), (Coleoptera: Bostrichidae) lesser grain borer, at different periods of time after exposure. Exposure to LLINs resulted in multiple-fold reductions in the distance moved and elevated angular velocity in both species that quickly took effect and persisted even after 168 h compared with adults exposed to control netting. R. dominica was somewhat more susceptible than T. castaneum to LLINs. Finally, the dispersal capacity of both species, measured as ability to move to a remote resource patch, was significantly impaired or absent after exposure to LLINs compared to adults exposed to control netting. Our results demonstrate that LLINs are a promising new technology for reducing infestation by stored product insects since even short exposures limit movement and ultimately lead to knockdown and death.
All‐polymer solar cells (all‐PSCs) offer unique morphology stability for the application as flexible devices, but the lack of high‐performance polymer acceptors limits their power conversion ...efficiency (PCE) to a value lower than those of the PSCs based on fullerene derivative or organic small molecule acceptors. We herein demonstrate a strategy to synthesize a high‐performance polymer acceptor PZ1 by embedding an acceptor–donor–acceptor building block into the polymer main chain. PZ1 possesses broad absorption with a low band gap of 1.55 eV and high absorption coefficient (1.3×105 cm−1). The all‐PSCs with the wide‐band‐gap polymer PBDB‐T as donor and PZ1 as acceptor showed a record‐high PCE of 9.19 % for the all‐PSCs. The success of our polymerization strategy can provide a new way to develop efficient polymer acceptors for all‐PSCs.
Energy conversion: Embedding an acceptor–donor–acceptor‐structured organic semiconductor building block into a polymer main chain creates an excellent low‐band‐gap polymer acceptor with red‐shifted absorption and a high absorption coefficient. The polymer acceptor provides a record‐high power conversion efficiency of 9.19 % for all‐polymer solar cells.
To investigate the feasibility of intensity-modulated radiation therapy (IMRT) with or without chemotherapy, and to assess toxicities, failure patterns, and survivals in patients with nasopharyngeal ...carcinoma (NPC).
Radiation consisted of 70 Gy given to the planning target volumes of primary tumor plus any N+ disease and 59.4 Gy given to subclinical disease, delivered over 33 treatment days. Patients with stage T2b or greater or with N+ disease also received concurrent cisplatin (100 mg/m(2)) on days 1, 22, and 43 followed by adjuvant cisplatin (80 mg/m(2)) on day 1; fluorouracil (1,000 mg/m(2)/d) on days 1 through 4 administered every 4 weeks for three cycles. Tumor, clinical status, and acute/late toxicities were assessed. The primary objective was to test the transportability of IMRT to a multi-institutional setting.
Between February 2003 and November 2005, 68 patients with stages I through IVB NPC (of which 93.8% were WHO types 2 and 3) were enrolled. Prescribed IMRT (target delineation) was given to 83.8%, whereas 64.9% received chemotherapy per protocol. The estimated 2-year local progression-free (PF), regional PF, locoregional PF, and distant metastasis-free rates were 92.6%, 90.8%, 89.3%, and 84.7%, respectively. The estimated 2-year PF and overall survivals were 72.7% and 80.2%, respectively. Acute grade 4 mucositis occurred in 4.4%, and the worst late grade 3 toxicities were as follows: esophagus, 4.7%; mucous membranes, 3.1%; and xerostomia, 3.1%. The rate of grade 2 xerostomia at 1 year from start of IMRT was 13.5%. Only two patients complained of grade 3 xerostomia, and none had grade 4 xerostomia.
It was feasible to transport IMRT with or without chemotherapy in the treatment of NPC to a multi-institutional setting with 90% LRPF rate reproducing excellent reports from single institutions. Minimal grade 3 and lack of grade 4 xerostomia were encouraging.
Two insecticides (deltamethrin and pirimiphos-methyl) were evaluated in laboratory assays as grain protectants when applied as a total percentage of a maize mass to control adult Prostephanus ...truncatus and Sitophilus zeamais. All experiments were conducted at the University of Thessaly in Greece at 30°C and 65% RH under continuous darkness. Either insecticide was applied to 20 g of maize placed in a vial or to the upper one half, one fourth, or one-eighth layer of the maize, then insects were either added to the vials before or after the maize in a completely randomized block design CRBD with n = 9 replicates. Mortality, progeny production, and insect damaged kernels (IDK) were then evaluated for each vial. Insect introduction method (before or after) did not have any impact on any of the variables. Mortality was nearly 100% for all treatments for both insecticides for P. truncatus. Subsequently, progeny production and the number of insect damaged kernels were very low or zero for P. truncatus. Mortality of S. zeamais remained low across layer treatments for deltamethrin. However, S. zeamais was easily controlled by pirimiphos-methyl. The results of this laboratory study show that while deltamethrin and pirimiphos-methyl have some effectiveness as a layer treatment on a column of maize, efficacy will be dependent on the target species, and the depth of the treated layer, as well as the location on which the insects are present. Graphical Abstract
Reirradiation of head and neck (H&N) cancer is a clinical challenge. Proton radiation therapy (PRT) offers dosimetric advantages for normal tissue sparing and may benefit previously irradiated ...patients. Here, we report our initial experience with the use of PRT for H&N reirradiation, with focus on clinical outcomes and toxicity.
We retrospectively reviewed the records of patients who received H&N reirradiation with PRT from April 2011 through June 2015. Patients reirradiated with palliative intent or without prior documentation of H&N radiation therapy were excluded. Radiation-related toxicities were recorded according to the Common Terminology Criteria for Adverse Events Version 4.0.
The conditions of 60 patients were evaluated, with a median follow-up time of 13.6 months. Fifteen patients (25%) received passive scatter proton therapy (PSPT), and 45 (75%) received intensity modulated proton therapy (IMPT). Thirty-five patients (58%) received upfront surgery, and 44 (73%) received concurrent chemotherapy. The 1-year rates of locoregional failure-free survival, overall survival, progression-free survival, and distant metastasis-free survival were 68.4%, 83.8%, 60.1%, and 74.9%, respectively. Eighteen patients (30%) experienced acute grade 3 (G3) toxicity, and 13 (22%) required a feeding tube at the end of PRT. The 1-year rates of late G3 toxicity and feeding tube independence were 16.7% and 2.0%, respectively. Three patients may have died of reirradiation-related effects (1 acute and 2 late).
Proton beam therapy can be a safe and effective curative reirradiation strategy, with acceptable rates of toxicity and durable disease control.
Canada's airports are unique in the world as a system of private, no-share capital, not-for-profit organizations. This paper reviews the evolution Canada's airport system and airport policy over the ...last 30 years and provides an overview of airport performance including an assessment of the likely proceeds should the Canadian government decide to sell its eight largest airports to private investors. The review reveals an airport system with a heavy "user pay" orientation that has become reliant on "airport improvement fees" charged to passengers, over and above regular aeronautical charges, in order to finance the substantial investments in infrastructure made by airport authorities. The paper highlights criticisms of the current airport system that have endured for over 20 years and shows how recent recommendations to sell our airports to private investors reveals an underlying tension regarding whether airports should be regarded as "spark plugs" that create wider economic benefits or "toll booths" that generate government revenues. The paper argues that a viable alternative to selling off airports to private investors is to reintroduce legislation first introduced in 2003 and again in 2006, which, despite broad political support, never became law.
PDF
